Investment Summary |
|
|---|---|
| Date | 2016-10-12 |
| Target | ObsEva |
| Sector | Life Science |
| Investor(s) | HBM Partners |
| Deal Type | Venture |
SEARCH BY
| Category | Private Equity Firm |
|---|---|
| Founded | 2001 |
| PE ASSETS | 2.1B USD |
| Size | Large |
| Type | Sector Focused |
HBM Partners is a private investment firm focused on investing in entrepreneurial biopharma and other healthcare-related companies in Europe, North America, India and other Emerging Markets. HBM looks to invest $5 to $50 million per transaction and will consider private and public companies. HBM Partners was established in 2001 and is headquartered in Zug, Switzerland.
| DEAL STATS | # |
|---|---|
| Overall | 12 of 65 |
| Sector: Life Science M&A | 10 of 56 |
| Type: Venture M&A Deals | 7 of 52 |
| Country: Switzerland M&A | 2 of 4 |
| Year: 2016 M&A | 3 of 3 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2016-05-10 |
Aptinyx
Evanston, Illinois, United States Aptinyx is a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel, proprietary, and synthetic small molecules for the treatment of brain and nervous system disorders. Aptinyx was founded in 2015 and is based in Evanston, Illinois. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2017-01-01 |
Swixx Biopharma
Baar, Switzerland Swixx BioPharma is a specialized distributor of rare diseases, Rx and OTC medicinal products in Central & Eastern Europe, and acts as a true commercialization partner for Biotech & Pharma companies in this area. Swixx Biopharma was founded in 2014 and is based in Baar, Switzerland. |
Buy | - |
